A Study of NB003 in Patients With Advanced Malignancies
Phase 1
Recruiting
- Conditions
- Gastrointestinal stromal tumor, Solid tumors, MelanomaMedDRA version: 21.1Level: PTClassification code: 10051066Term: Gastrointestinal stromal tumour Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10065252Term: Solid tumor Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10053571Term: Melanoma Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2022-502401-15-00
- Lead Sponsor
- ingbo Newbay Technology Development Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 290
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method